ProSomnus announced today that it raised $38 million through a strategic investment from Catalio Capital Management.
Nearly 30 million Americans struggle with obstructive sleep apnea, yet many avoid the standard treatment, CPAP. Some get frustrated with the mask, while ...
Everyday Health on MSN
CPAP vs. medication: Which obstructive sleep apnea (OSA) treatment is more effective?
Compare the efficacy, benefits, and drawbacks of CPAP therapy and tirzepatide (Zepbound), two of the best treatments for sleep apnea.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results